HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Boulle, A Articles by Ford, N Search for Related Content PubMed PubMed Citation Articles by Boulle, A Articles by Ford, N

Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?

¹ University of Cape Town, South Africa
² Médicins San Frontières, South Africa

Correspondence to:
A Boulle, University of Cape Town, PO Box 13203 Mowbray, South Africa; andrew.boulle@uct.ac.za

Accepted 2 October 2007

The first 150 words of the full text of this article appear below.

In recent years the case for antiretroviral therapy (ART) in those countries hardest hit by the HIV pandemic is seldom contested. Prior to the widespread availability of antiretroviral therapy in many developing countries, there were however frequent concerns expressed about the safety and feasibility of promoting widespread access to ART in countries such as those in Southern Africa. These concerns were premised on the potential "anarchy" that might be the result of weak health systems leading to widespread virological resistance,^{1 2} on the grounds that there were more cost-effective interventions available given the limited funding baskets at the time,³ and on the potential to do more harm than good if introducing large and complex new interventions into already weak and fragmented health systems, further increasing inequities.^{4 5}

The first public-sector ART treatment programmes in developing countries (with the exception of Brazil) date back to 2000,⁶ and data are now emerging on the . . . [Full text of this article]